Síndrome coronario agudo. Código infarto en urgencias

  1. Martínez Selles, M. 1
  2. Gargallo García, E. 2
  3. Fernández Cardona, M. 2
  4. Sevilla Fernández, J.A. 3
  1. 1 Servicios de Cardiología, Hospital General Universitario Gregorio Marañón, Madrid, España CIBERCV, Universidad Europea, Madrid, España Departamento de Medicina, Universidad Complutense de Madrid, Madrid, España
  2. 2 Servicios de Urgencias, Hospital General Universitario Gregorio Marañón, Madrid, España CIBERCV, Universidad Europea, Madrid, España
  3. 3 Servicios de Urgencias, Hospital General Universitario Gregorio Marañón, Madrid, España CIBERCV, Universidad Europea, Madrid, España Departamento de Medicina, Universidad Complutense de Madrid, Madrid, España
Show affiliations +
Journal:
Medicine: Programa de Formación Médica Continuada Acreditado

ISSN: 0304-5412

Year of publication: 2023

Issue Title: Urgencias (I):Urgencias cardiovasculares

Series: 13

Issue: 87

Pages: 5138-5145

Type: Article

DIALNET GOOGLE SCHOLAR

More publications in: Medicine: Programa de Formación Médica Continuada Acreditado

Abstract

Acute coronary syndrome (ACS) is a set of clinical entities caused by the partial or total obstruction of a coronary artery related, in most cases, to the rupture or erosion of a vulnerable atherosclerotic plaque that produces acute ischemia and, in the most severe cases, myocardial necrosis. ACS is a potentially fatal pathology that requires early diagnosis and treatment. For this reason, patients with compatible symptoms, fundamentally chest pain, must have an electrocardiogram within the first ten minutes of their arrival to the emergency department or healthcare service. The pillars of treatment include monitoring, antithrombotic treatment and treatment for reducing cardiovascular events, optimization of the supply-demand imbalance in the myocardium, and improvement in perfusion. The latter must be very early in patients with ACS with ST segment elevation, preferentially by means of a primary angioplasty or, if this cannot be performed in the first 120 minutes after medical contact, with fibrinolytic agents. Prevention of ACS through a healthy lifestyle, the early identification and treatment of risk factors, and education on the symptoms of a possible ACS are important for reducing the disease burden and improving the results of treatment.

Bibliographic References

  • Díez Delhoyo F, Gutiérrez Ibañes E, Sanz Ruiz R, Vázquez Álvarez ME, González Saldívar H, Rivera Juárez A. Prevalence of microvascular and endothelial dysfunction in the nonculprit territory in patients with acute myocardial infarction. Circ Cardiovasc Interv. 2019;12:e007257.
  • Postigo A, Díez Delhoyo F, Devesa C, Bruña V, Clavero Olmos M, Vicent L. Clinical profile, anatomical features and long-term outcome of acute coronary syndromes in human immunodeficiency virus-infected patients. Intern Med J. 2020;50:1518-23.
  • Valero Masa MJ, Velásquez Rodríguez J, Diez Delhoyo F, Devesa C, Juárez M, Sousa Casasnovas I. Sex differences in acute myocardial infarction: Is it only the age? Int J Cardiol. 2017;231:36-41.
  • Vicent L, Martínez Sellés M. Circadian rhythms, cardiac arrhythmias and sudden death. Front Biosci (Landmark Ed). 2021;26:1305-11.
  • Vicent L, Ariza Solé A, González Juanatey JR, Uribarri A, Ortiz J, López de Sá E. Cardiac arrest and myocardial infarction notified after marathon or similar effort (CAMINAMOS) registry. Exercise-related severe cardiac events. Scand J Med Sci Sports. 2018;28:1404-11.
  • Ducrocq G, González Juanatey JR, Puymirat E, Lemesle G, Cachanado M, Durand Zaleski I. Effect of a restrictive vs liberal blood transfusion strategy on major cardiovascular events among patients with acute myocardial infarction and anemia: The REALITY Randomized Clinical Trial. JAMA. 2021;325:552-60.
  • Velásquez-Rodríguez J, Diez-Delhoyo F, Valero-Masa MJ, Vicent L, Devesa C, Sousa-Casasnovas I, et al. Prognostic impact of age and hemoglobin in acute st-segment elevation myocardial infarction treated with reperfusion therapy. Am J Cardiol. 2017 15;119:1909-16.
  • Harrington J, Jones WS, Udell JA, Hannan K, Bhatt DL, Anker SD. Acute decompensated heart failure in the setting of acute coronary syndrome. JACC Heart Fail. 2022;10:404-14.
  • Martínez Sellés M, Juárez M, Marina Breysse M, Lillo Castellano JM, Ariza A. Rational and design of ST-segment elevation not associated with acute cardiac necrosis (LESTONNAC). A prospective registry for validation of a deep learning system assisted by artificial intelligence. J Electrocardiol. 2021;69:140-4.
  • Vicent L, Velásquez Rodríguez J, Valero Masa MJ, Díez Delhoyo F, González Saldívar H. Predictors of high Killip class after ST segment elevation myocardial infarction in the era of primary reperfusion. Int J Cardiol. 2017;248:46-50.
  • Vicent L, Bruña V, Devesa C, Sousa Casasnovas I, Juárez M, Alcalá L. Ticagrelor and infection risk in patients with coronary artery disease. Cardiology. 2021;146:698-704.
  • Collet JP, Thiele H, Barbato E, Barthélémy O, Bauersachs J, Bhatt DL. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021;42:1289-367.
  • Martínez Sellés M, Hernández Pérez FJ, Uribarri A, Martín Villén L, Zapata L, Alonso JJ. Cardiogenic shock code 2023. Expert document for a multidisciplinary organization that allows quality care. Rev Esp Cardiol (Engl Ed). 2022:S1885-5857(22)00330-9.
  • Puerto E, Viana Tejedor A, Martínez Sellés M, Domínguez Pérez L, Moreno G, Martín Asenjo R. Temporal trends in mechanical complications of acute myocardial infarction in the elderly. J Am Coll Cardiol. 2018;72:959-66.
  • Velásquez Rodríguez J, Bruña V, Vicent L, Díez Delhoyo F, Valero Masa MJ, Sousa Casasnovas I. Influence of left ventricular systolic function on the long-term benefit of beta-blockers after ST-segment elevation myocardial infarction. Rev Port Cardiol (Engl Ed). 2021;40:285-90.
  • García Blas S, Cordero A, Díez Villanueva P, Martínez Avial M, Ayesta A, Ariza Solé A. Acute coronary syndrome in the older patient. J Clin Med. 2021;10:4132.
  • Ariza Solé A, Alegre O, Elola FJ, Fernández C, Formiga F, Martínez Sellés M. Management of myocardial infarction in the elderly. Insights from Spanish Minimum Basic Data Set. Eur Heart J Acute Cardiovasc Care. 2019;8:242-51.
  • Guerrero C, Ariza Solé A, Formiga F, Martínez Sellés M, Vidán MT, Aboal J. Applicability of the PRECISE-DAPT score in elderly patients with myocardial infarction. J Geriatr Cardiol. 2018;15:713-7.
  • Sanchis J, Bueno H, Miñana G, Guerrero C, Martí D, MartínezSellés M. Routine invasive versus conservative strategy in older adults with frailty and non-ST-segment elevation acute myocardial infarction. JAMA Intern Med 2023;183(5):407-15.
  • Damluji AA, Forman DE, Wang TY, Chikwe J, Kunadian V, Rich MW. Management of Acute Coronary Syndrome in the Older Adult Population: A Scientific Statement From the American Heart Association. Circulation. 2023;147(3):e32-e62.
  • Vicent L, Ariza Solé A, Díez Villanueva P, Alegre O, Sanchís J, López Palop R. Statin treatment and prognosis of elderly patients discharged after non-ST segment elevation acute coronary syndrome. Cardiology. 2019;143:14-21.
  • Díez Villanueva P, Vera A, Ariza Solé A, Alegre O, Formiga F, López Palop R. Mitral regurgitation and prognosis after non-ST-segment elevation myocardial infarction in very old patients. J Am Geriatr Soc. 2019;67:1641-8.
  • Bruña V, Velásquez Rodríguez J, Valero Masa MJ, Pérez Guillem B, Vicent L, Díez Delhoyo F. Prognostic of interatrial block after an acute STsegment elevation myocardial infarction. Cardiology. 2019;142:109-15.
  • Bernal E, Bayés Genís A, Ariza Solé A, Formiga F, Vidán MT, Escobar Robledo LA. Interatrial block, frailty and prognosis in elderly patients with myocardial infarction. J Electrocardiol. 2018;51:1-7.
  • Álvarez Álvarez B, Cid Álvarez AB, Redondo Diéguez A, Sanmartín Pena X, López Otero D, Avila Carrillo A. Short-term and long-term validation of the fastest score in patients with ST-elevation myocardial infarction after primary angioplasty. Int J Cardiol. 2018;269:19-22.
  • Díez Delhoyo F, Valero Masa MJ, Velásquez Rodríguez J, Devesa Cordero C, Sousa Casasnovas I, Juárez M. Very low risk ST-segment elevation myocardial infarction? It exists and may be easily identified. Int J Cardiol. 2017;228:615-20.
Data source: Dialnet